Portfolio company
Stem Pharm
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops human neural organoids and synthetic biomaterials for pharmaceutical partners to model neurological diseases and screen drug candidates.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
StemoniX
This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.
BrainZell
The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.
Epiloid Biotechnology
This company provides preclinical research services using human brain organoids to help pharmaceutical firms test the efficacy and safety of neurological drug candidates.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
Treefrog Therapeutics
This company develops a stem cell production platform to provide regenerative medicine therapies for pharmaceutical firms and patients with neurodegenerative diseases.
Greenstone Biosciences
This company provides stem cell-derived models and artificial intelligence platforms to pharmaceutical companies and academic researchers for drug discovery and toxicity testing.
